2nd Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$80,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights

LobbyistCovered position, as disclosed
BEATRIZ DUQUE —
ABBEY ROUDEBUSH New —

Contacted: Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Equal Employment Opportunity Commission (EEOC); SENATE; HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ)

Health Issues HCR

Health care reform, Medicare, Medicaid, access to care

LobbyistCovered position, as disclosed
BEATRIZ DUQUE —
ABBEY ROUDEBUSH New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); Equal Employment Opportunity Commission (EEOC); Justice, Dept of (DOJ); White House Office; SENATE; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

NIH, CDC, FDA and health care/public health appropriations

LobbyistCovered position, as disclosed
BEATRIZ DUQUE —
ABBEY ROUDEBUSH New —

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Equal Employment Opportunity Commission (EEOC); SENATE; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.